209 related articles for article (PubMed ID: 17575223)
1. Human leukocyte antigen class I antigen expression is an independent prognostic factor in ovarian cancer.
Rolland P; Deen S; Scott I; Durrant L; Spendlove I
Clin Cancer Res; 2007 Jun; 13(12):3591-6. PubMed ID: 17575223
[TBL] [Abstract][Full Text] [Related]
2. HLA class I antigen down-regulation in primary ovary carcinoma lesions: association with disease stage.
Vitale M; Pelusi G; Taroni B; Gobbi G; Micheloni C; Rezzani R; Donato F; Wang X; Ferrone S
Clin Cancer Res; 2005 Jan; 11(1):67-72. PubMed ID: 15671529
[TBL] [Abstract][Full Text] [Related]
3. Human leukocyte antigen class I, MHC class I chain-related molecule A, and CD8+/regulatory T-cell ratio: which variable determines survival of cervical cancer patients?
Jordanova ES; Gorter A; Ayachi O; Prins F; Durrant LG; Kenter GG; van der Burg SH; Fleuren GJ
Clin Cancer Res; 2008 Apr; 14(7):2028-35. PubMed ID: 18381941
[TBL] [Abstract][Full Text] [Related]
4. Cytoplasmic p27 expression is an independent prognostic factor in ovarian cancer.
Duncan TJ; Al-Attar A; Rolland P; Harper S; Spendlove I; Durrant LG
Int J Gynecol Pathol; 2010 Jan; 29(1):8-18. PubMed ID: 19952944
[TBL] [Abstract][Full Text] [Related]
5. Subcellular localization of activated leukocyte cell adhesion molecule is a molecular predictor of survival in ovarian carcinoma patients.
Mezzanzanica D; Fabbi M; Bagnoli M; Staurengo S; Losa M; Balladore E; Alberti P; Lusa L; Ditto A; Ferrini S; Pierotti MA; Barbareschi M; Pilotti S; Canevari S
Clin Cancer Res; 2008 Mar; 14(6):1726-33. PubMed ID: 18347173
[TBL] [Abstract][Full Text] [Related]
6. HLA class I antigen expression is associated with a favorable prognosis in early stage non-small cell lung cancer.
Kikuchi E; Yamazaki K; Torigoe T; Cho Y; Miyamoto M; Oizumi S; Hommura F; Dosaka-Akita H; Nishimura M
Cancer Sci; 2007 Sep; 98(9):1424-30. PubMed ID: 17645781
[TBL] [Abstract][Full Text] [Related]
7. Vascular endothelial growth factor expression in ovarian cancer: a model for targeted use of novel therapies?
Duncan TJ; Al-Attar A; Rolland P; Scott IV; Deen S; Liu DT; Spendlove I; Durrant LG
Clin Cancer Res; 2008 May; 14(10):3030-5. PubMed ID: 18483368
[TBL] [Abstract][Full Text] [Related]
8. Novel molecular subtypes of serous and endometrioid ovarian cancer linked to clinical outcome.
Tothill RW; Tinker AV; George J; Brown R; Fox SB; Lade S; Johnson DS; Trivett MK; Etemadmoghadam D; Locandro B; Traficante N; Fereday S; Hung JA; Chiew YE; Haviv I; ; Gertig D; DeFazio A; Bowtell DD
Clin Cancer Res; 2008 Aug; 14(16):5198-208. PubMed ID: 18698038
[TBL] [Abstract][Full Text] [Related]
9. Human leukocyte antigen-G protein expression is an unfavorable prognostic predictor of hepatocellular carcinoma following curative resection.
Cai MY; Xu YF; Qiu SJ; Ju MJ; Gao Q; Li YW; Zhang BH; Zhou J; Fan J
Clin Cancer Res; 2009 Jul; 15(14):4686-93. PubMed ID: 19584149
[TBL] [Abstract][Full Text] [Related]
10. Correlation of human leukocyte antigen-G (HLA-G) expression and disease progression in epithelial ovarian cancer.
Jung YW; Kim YT; Kim SW; Kim S; Kim JH; Cho NH; Kim JW
Reprod Sci; 2009 Nov; 16(11):1103-11. PubMed ID: 19692629
[TBL] [Abstract][Full Text] [Related]
11. Survival of ovarian cancer patients overexpressing the tumour antigen p53 is diminished in case of MHC class I down-regulation.
Leffers N; Lambeck AJ; de Graeff P; Bijlsma AY; Daemen T; van der Zee AG; Nijman HW
Gynecol Oncol; 2008 Sep; 110(3):365-73. PubMed ID: 18571704
[TBL] [Abstract][Full Text] [Related]
12. Analysis and clinical relevance of human leukocyte antigen class I, heavy chain, and beta2-microglobulin downregulation in breast cancer.
Morabito A; Dozin B; Salvi S; Pasciucco G; Balbi G; Laurent S; Pastorino S; Carli F; Truini M; Bruzzi P; Del Mastro L; Pistillo MP
Hum Immunol; 2009 Jul; 70(7):492-5. PubMed ID: 19410618
[TBL] [Abstract][Full Text] [Related]
13. HLA-G expression in effusions is a possible marker of tumor susceptibility to chemotherapy in ovarian carcinoma.
Davidson B; Elstrand MB; McMaster MT; Berner A; Kurman RJ; Risberg B; Trope CG; Shih IeM
Gynecol Oncol; 2005 Jan; 96(1):42-7. PubMed ID: 15589578
[TBL] [Abstract][Full Text] [Related]
14. ErbB-3 predicts survival in ovarian cancer.
Tanner B; Hasenclever D; Stern K; Schormann W; Bezler M; Hermes M; Brulport M; Bauer A; Schiffer IB; Gebhard S; Schmidt M; Steiner E; Sehouli J; Edelmann J; Läuter J; Lessig R; Krishnamurthi K; Ullrich A; Hengstler JG
J Clin Oncol; 2006 Sep; 24(26):4317-23. PubMed ID: 16896008
[TBL] [Abstract][Full Text] [Related]
15. Expression of human leukocyte antigen G (HLA-G) correlates with poor prognosis in gastric carcinoma.
Yie SM; Yang H; Ye SR; Li K; Dong DD; Lin XM
Ann Surg Oncol; 2007 Oct; 14(10):2721-9. PubMed ID: 17564748
[TBL] [Abstract][Full Text] [Related]
16. Epithelial human leukocyte antigen-DR expression predicts reduced recurrence rates and prolonged survival in rectal cancer patients.
de Bruin EC; van de Velde CJ; van Krieken JH; Marijnen CA; Medema JP
Clin Cancer Res; 2008 Feb; 14(4):1073-9. PubMed ID: 18281539
[TBL] [Abstract][Full Text] [Related]
17. Expression and prognostic significance of cyclin D3 in ovarian adenocarcinomas.
Levidou G; Korkolopoulou P; Thymara I; Vassilopoulos I; Saetta AA; Gakiopoulou H; Konstantinidou A; Kairi-Vassilatou E; Pavlakis K; Patsouris E
Int J Gynecol Pathol; 2007 Oct; 26(4):410-7. PubMed ID: 17885491
[TBL] [Abstract][Full Text] [Related]
18. The predictive value of HLA class I tumor cell expression and presence of intratumoral Tregs for chemotherapy in patients with early breast cancer.
de Kruijf EM; van Nes JG; Sajet A; Tummers QR; Putter H; Osanto S; Speetjens FM; Smit VT; Liefers GJ; van de Velde CJ; Kuppen PJ
Clin Cancer Res; 2010 Feb; 16(4):1272-80. PubMed ID: 20145162
[TBL] [Abstract][Full Text] [Related]
19. Diagnostic and prognostic role of the insulin growth factor pathway members insulin-like growth factor-II and insulin-like growth factor binding protein-3 in serous effusions.
Slipicevic A; Øy GF; Askildt IC; Holth A; Hellesylt E; Flørenes VA; Davidson B
Hum Pathol; 2009 Apr; 40(4):527-37. PubMed ID: 19121847
[TBL] [Abstract][Full Text] [Related]
20. Prognostic value of Ca 125 levels during primary therapy.
Markmann S; Gerber B; Briese V
Anticancer Res; 2007; 27(4A):1837-9. PubMed ID: 17649781
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]